Cowen Prime Advisors LLC Pharming Group N.V. Call Options Transaction History
Cowen Prime Advisors LLC
- $287 Million
- Q2 2023
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PHAR
# of Institutions
7Shares Held
74.3KCall Options Held
0Put Options Held
0-
Silverberg Bernstein Capital Management LLC Armonk, NY48KShares$441,5720.43% of portfolio
-
Morgan Stanley New York, NY2.6KShares$23,9190.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ483Shares$4,4430.0% of portfolio
-
Farther Finance Advisors, LLC San Francisco, CA11Shares$1010.0% of portfolio
-
Ubs Group Ag10Shares$920.0% of portfolio
About Pharming Group N.V.
- Ticker PHAR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,241,400
- Market Cap $600M
- Description
- Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company's lead product is Ruconest, a recombinant human C1 esterase inhibitor that is used for the tre...